SUMMARY
A-REITs had a strong recovery in the last quarter of 2023 to finish the year up 17.6%. This was driven by optimism on the back of the U.S. Fed commentary that inflation and interest rates have peaked – with potential rate cuts now firmly on the horizon for 2024. Our strategy of investing in high-quality REITs with a strong balance sheet and visibility in earnings growth delivered a return of +18.10%, outperforming the benchmark by +1.20% over the 2023 calendar year.
The divergence in performance within the sector widened throughout the year. Growth stocks (GMG and HMC) and 2022-laggards (SGP and GPT) were amongst the best performers, whilst REITs with office exposure and/or high gearing (CMW, GOZ, CLW) materially underperformed.
Key contributors to the Fund’s performance include the overweight positions in NextDC Limited (NXT +52.29%) and Stockland Group (SGP +29.24%), whilst the Fund’s holdings in Qualitas Limited (QAL -13.92%) and HealthCo Healthcare and Wellness REIT (HCW -8.47%) detracted from performance.
As we move into the start of 2024 we will look to deliver a ‘year in review’ Fund update. Please let us know any questions you would like us to cover, either specific to the sector, Portfolio, or any portfolio holdings below.